Literature DB >> 9310143

Clinicopathological characteristics of primary breast cancer in older geriatric women: a study of 39 Japanese patients over 80 years old.

Y Morishita1, H Tsuda, T Fukutomi, K Mukai, Y Shimosato, S Hirohashi.   

Abstract

The number of primary breast cancers occurring in elderly women is increasing in Japan. Optimization of treatment regimens in this age group requires precise evaluation of the biological aggressiveness of these tumors as well as the performance status and extent of tumor spread. In 39 breast cancer patients who were at least 80 years old, we examined several parameters; the form of surgical therapy, the lymph node status, presence or absence of distant metastases, the histological type and grade of atypia, and overexpression of the c-erbB-2 oncoprotein in the cancer cells. They were correlated with the clinical outcome of the patient. Of the 33 patients who underwent a mastectomy and axillary lymph node dissection, five died from cancer recurrence. Only one out of 22 patients without lymph node metastases died from cancer, while four out of the eight patients with metastases to three or more lymph nodes died from cancer recurrence within 2.7 years of surgery. The overall survival curves also differed between patients with low-risk histological tumors or grade 1 or 2 invasive ductal carcinoma and those with grade 3 invasive ductal/lobular carcinoma. Overexpression of c-erbB-2 also affected survival. Regional recurrence occurred in three out of the six patients for whom only lumpectomy or simple mastectomy was performed. These results indicate that, although primary breast cancer occurring in patients over 80 years old was largely of low-grade malignancy, patients with three or more lymph node metastases, invasive ductal/lobular carcinomas of grade 3, or c-erbB-2 overexpression frequently exhibited an aggressive clinical course.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9310143      PMCID: PMC5921482          DOI: 10.1111/j.1349-7006.1997.tb00438.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  13 in total

1.  Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.

Authors:  C Wright; B Angus; S Nicholson; J R Sainsbury; J Cairns; W J Gullick; P Kelly; A L Harris; C H Horne
Journal:  Cancer Res       Date:  1989-04-15       Impact factor: 12.701

2.  Age-dependent growth rate of primary breast cancer.

Authors:  P G Peer; J A van Dijck; J H Hendriks; R Holland; A L Verbeek
Journal:  Cancer       Date:  1993-06-01       Impact factor: 6.860

3.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

4.  Breast cancer in the elderly.

Authors:  S E Singletary; R Shallenberger; V F Guinee
Journal:  Ann Surg       Date:  1993-11       Impact factor: 12.969

5.  Treatment of carcinoma of the breast in the older geriatric patient.

Authors:  R S Swanson; J Sawicka; W C Wood
Journal:  Surg Gynecol Obstet       Date:  1991-12

Review 6.  Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1992-01-04       Impact factor: 79.321

Review 7.  Breast cancer and aging.

Authors:  J A Stewart; R S Foster
Journal:  Semin Oncol       Date:  1989-02       Impact factor: 4.929

8.  Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.

Authors:  H J BLOOM; W W RICHARDSON
Journal:  Br J Cancer       Date:  1957-09       Impact factor: 7.640

9.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

10.  Immunohistochemical study on overexpression of c-erbB-2 protein in human breast cancer: its correlation with gene amplification and long-term survival of patients.

Authors:  H Tsuda; S Hirohashi; Y Shimosato; Y Tanaka; T Hirota; S Tsugane; M Shiraishi; K Toyoshima; T Yamamoto; M Terada
Journal:  Jpn J Cancer Res       Date:  1990-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.